Trial Profile

A Phase 1/2/3, Randomized, Observer-Blind Study of S-268019 in Participants Aged 5 to 11 Years (Part 1)(COVID-19)

Status: Recruiting

Phase of Trial: Phase II/III

Latest Information Update: 16 Oct 2024

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs S 268019 (Primary)
Indications COVID 2019 infections
Focus Adverse reactions; Registrational; Therapeutic Use
Sponsors Shionogi

Most Recent Events

17 Jan 2023 According to a Shionog media release, the company has initiated a Phase 1/2/3 clinical trial (part2) and Phase 3 additional dose clinical trial in Japanese pediatric subjects of its vaccine S-268019
22 Jul 2022 New trial record
19 Jul 2022 According to a Shionog media release, the company has initiated part I of this trial in Japanese pediatric subjects .

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com